No Data
No Data
COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director
Cosciens Biopharma Hires Recruiting Firm to Find Next CEO, Says Integration of Ceapro Progressing
COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs
Cosciens Biopharma Says Phase 3 DETECT-Trial Top-line Results Show Efficacy Standpoint Not Met
Express News | US-Listed Shares of Cosciens Biopharma Fall 50.5% Premarket as Drug for Growth Hormone Deficiency Fails to Meet Main Goal of Late-Stage Study
COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
No Data